Literature DB >> 32343504

Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young.

Thomas J Oxley1, J Mocco1, Shahram Majidi1, Christopher P Kellner1, Hazem Shoirah1, I Paul Singh1, Reade A De Leacy1, Tomoyoshi Shigematsu1, Travis R Ladner1, Kurt A Yaeger1, Maryna Skliut1, Jesse Weinberger1, Neha S Dangayach1, Joshua B Bederson1, Stanley Tuhrim1, Johanna T Fifi1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32343504      PMCID: PMC7207073          DOI: 10.1056/NEJMc2009787

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
To rapidly communicate information on the global clinical effort against Covid-19, the We report five cases of large-vessel stroke in patients younger than 50 years of age who presented to our health system in New York City. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was diagnosed in all five patients. Cough, headache, and chills lasting 1 week developed in a previously healthy 33-year-old woman (Patient 1) (Table 1). She then had progressive dysarthria with both numbness and weakness in the left arm and left leg over a period of 28 hours. She delayed seeking emergency care because of fear of Covid-19. When she presented to the hospital, the score on the National Institutes of Health Stroke Scale (NIHSS) was 19 (scores range from 0 to 42, with higher numbers indicating greater stroke severity), and computed tomography (CT) and CT angiography showed a partial infarction of the right middle cerebral artery with a partially occlusive thrombus in the right carotid artery at the cervical bifurcation. Patchy ground-glass opacities in bilateral lung apices were seen on CT angiography, and testing to detect SARS-CoV-2 was positive. Antiplatelet therapy was initiated; it was subsequently switched to anticoagulation therapy. Stroke workup with echocardiography and magnetic resonance imaging of the head and neck did not reveal the source of the thrombus. Repeat CT angiography on hospital day 10 showed complete resolution of the thrombus, and the patient was discharged to a rehabilitation facility.
Table 1

Clinical Characteristics of Five Young Patients Presenting with Large-Vessel Stroke.*

VariablePatient 1Patient 2Patient 3Patient 4Patient 5
Age — yr3337394449
SexFemaleMaleMaleMaleMale
Medical history and risk factors for strokeNoneNoneHyperlipidemia, hypertensionUndiagnosed diabetesMild stroke, diabetes
MedicationsNoneNoneNoneNoneAspirin (81 mg),atorvastatin (80 mg)
NIHSS score
On admission1913162313
At 24 hr171141911
At last follow-up13(on day 14)5(on day 10)NA; intubated and sedated, with multiorgan failure19(on day 12)7(on day 4)
Outcome statusDischarged to rehabilitation facilityDischarged homeIntensive care unitStroke unitDischarged to rehabilitation facility
Time to presentation — hr2816828
Signs and symptoms of strokeHemiplegia on left side, facial droop, gaze preference, homonymous hemianopia, dysarthria, sensory deficitReduced level of consciousness, dysphasia, hemiplegia on right side, dysarthria, sensory deficitReduced level of consciousness, gaze preference to the right, left homonymous hemianopia, hemiplegia on left side, ataxiaReduced level of consciousness, global dysphasia, hemiplegia on right side, gaze preferenceReduced level of consciousness, hemiplegia on left side, dysarthria, facial weakness
Vascular territoryRight internal carotid arteryLeft middle cerebral arteryRight posterior cerebral arteryLeft middle cerebral arteryRight middle cerebral artery
Imaging for diagnosisCT, CTA, CTP, MRICT, CTA, MRICT, CTA, CTP, MRICT, CTA, MRICT, CTA, CTP
Treatment for strokeApixaban (5 mg twice daily)Clot retrieval, apixaban (5 mg twice daily)Clot retrieval, aspirin (81 mg daily)Intravenous t-PA, clot retrieval, hemicraniectomy, aspirin (81 mg daily)Clot retrieval, stent, aspirin (325 mg daily), clopidogrel (75 mg daily)
Covid-19 symptomsCough, headache, chillsNo symptoms; recently exposed to family member with PCR-positive Covid-19NoneLethargyFever, cough, lethargy
White-cell count — per mm378009900550090004900
Platelet count — per mm3427,000299,000135,000372,000255,000
Prothrombin time — sec13.313.414.412.815.2
Activated partial-thromboplastin time — sec25.042.727.726.937.0
Fibrinogen — mg/dl501370739443531
d-dimer — ng/ml46052223013,8001750
Ferritin — ng/ml71361564987596

Reference ranges are as follows: platelet count, 150,000 to 450,000 per cubic millimeter; prothrombin time, 12.3 to 14.9 seconds; activated partial-thromboplastin time, 25.4 to 34.9 seconds; fibrinogen, 175 to 450 mg per deciliter; d-dimer, 0 to 500 ng per milliliter; and ferritin, 30 to 400 ng per milliliter. CT denotes computed tomography, CTA CT angiography, CTP CT perfusion, MRI magnetic resonance imaging, NA not applicable, PCR polymerase chain reaction, and t-PA tissue plasminogen activator.

The patients were screened for smoking, hypertension, hyperlipidemia, diabetes, atrial fibrillation, congestive heart failure, illicit drug use, and neck trauma.

Scores on the National Institutes of Health Stroke Scale (NIHSS) range from 0 to 42, with higher numbers indicating more severe stroke.

Over a 2-week period from March 23 to April 7, 2020, a total of five patients (including the aforementioned patient) who were younger than 50 years of age presented with new-onset symptoms of large-vessel ischemic stroke. All five patients tested positive for Covid-19. By comparison, every 2 weeks over the previous 12 months, our service has treated, on average, 0.73 patients younger than 50 years of age with large-vessel stroke. On admission of the five patients, the mean NIHSS score was 17, consistent with severe large-vessel stroke. One patient had a history of stroke. Other pertinent clinical characteristics are summarized in Table 1. A retrospective study of data from the Covid-19 outbreak in Wuhan, China, showed that the incidence of stroke among hospitalized patients with Covid-19 was approximately 5%; the youngest patient in that series was 55 years of age.[1] Moreover, large-vessel stroke was reported in association with the 2004 SARS-CoV-1 outbreak in Singapore.[2] Coagulopathy and vascular endothelial dysfunction have been proposed as complications of Covid-19.[3] The association between large-vessel stroke and Covid-19 in young patients requires further investigation. Social distancing, isolation, and reluctance to present to the hospital may contribute to poor outcomes. Two patients in our series delayed calling an ambulance because they were concerned about going to a hospital during the pandemic.
  2 in total

1.  Large artery ischaemic stroke in severe acute respiratory syndrome (SARS).

Authors:  T Umapathi; Ai Ching Kor; N Venketasubramanian; C C Tchoyoson Lim; Boon Chuan Pang; Tseng Tsai Yeo; Cheng Chuan Lee; Poh Lian Lim; Kuperan Ponnudurai; Khoon Leong Chuah; Puay Hoon Tan; Dessmon Yeng Huoa Tai; Sze Peng Brenda Ang
Journal:  J Neurol       Date:  2004-10       Impact factor: 4.849

2.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321

  2 in total
  753 in total

1.  Cerebral Venous Thrombosis Associated with COVID-19.

Authors:  D D Cavalcanti; E Raz; M Shapiro; S Dehkharghani; S Yaghi; K Lillemoe; E Nossek; J Torres; R Jain; H A Riina; A Radmanesh; P K Nelson
Journal:  AJNR Am J Neuroradiol       Date:  2020-06-18       Impact factor: 3.825

Review 2.  The complement system in COVID-19: friend and foe?

Authors:  Anuja Java; Anthony J Apicelli; M Kathryn Liszewski; Ariella Coler-Reilly; John P Atkinson; Alfred Hj Kim; Hrishikesh S Kulkarni
Journal:  JCI Insight       Date:  2020-08-06

3.  Neurovascular Complications in COVID-19 Infection: Case Series.

Authors:  A M Franceschi; R Arora; R Wilson; L Giliberto; R B Libman; M Castillo
Journal:  AJNR Am J Neuroradiol       Date:  2020-06-11       Impact factor: 3.825

4.  Acute Common Carotid Artery Bifurcation Thrombus: An Emerging Pattern of Acute Strokes in Patients with COVID-19?

Authors:  E Gulko; W Gomes; S Ali; F Al-Mufti; H Mehta
Journal:  AJNR Am J Neuroradiol       Date:  2020-07-02       Impact factor: 3.825

5.  Reply.

Authors:  Michael F Goldberg; Morton F Goldberg; R Cerejo; A H Tayal
Journal:  AJNR Am J Neuroradiol       Date:  2020-07-09       Impact factor: 3.825

6.  Lung megakaryocytes display distinct transcriptional and phenotypic properties.

Authors:  Anthony K Yeung; Carlos Villacorta-Martin; Stephanie Hon; Jason R Rock; George J Murphy
Journal:  Blood Adv       Date:  2020-12-22

Review 7.  Neurovascular and perfusion imaging findings in coronavirus disease 2019: Case report and literature review.

Authors:  Matheus Dorigatti Soldatelli; Lázaro Faria do Amaral; Viviane Cordeiro Veiga; Salomón Soriano Ordinola Rojas; Samir Omar; Victor Hugo Rocha Marussi
Journal:  Neuroradiol J       Date:  2020-07-15

8.  Pressing Issues in COVID-19: Probable Cause to Seize SARS-CoV-2 for Its Preferential Involvement of Posterior Circulation Manifesting as Severe Posterior Reversible Encephalopathy Syndrome and Posterior Strokes.

Authors:  F D'Amore; G Vinacci; E Agosti; L P Cariddi; A V Terrana; F A Vizzari; M Mauri; A Giorgianni
Journal:  AJNR Am J Neuroradiol       Date:  2020-07-30       Impact factor: 3.825

Review 9.  Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review.

Authors:  Adeel S Zubair; Lindsay S McAlpine; Tova Gardin; Shelli Farhadian; Deena E Kuruvilla; Serena Spudich
Journal:  JAMA Neurol       Date:  2020-08-01       Impact factor: 18.302

Review 10.  SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation.

Authors:  Kiandokht Keyhanian; Raffaella Pizzolato Umeton; Babak Mohit; Vahid Davoudi; Fatemeh Hajighasemi; Mehdi Ghasemi
Journal:  J Neuroimmunol       Date:  2020-11-07       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.